Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    Live Webinar on Understanding and Implementing a Quality by Design Program

    View: 133

    Website https://bit.ly/2CsHrh5 | Want to Edit it Edit Freely

    Category Quality by design in pharmaceutical development, Quality by design FDA; QBDguidelines

    Deadline: February 27, 2019 | Date: February 27, 2019

    Venue/Country: Training Doyens 26468 E Walker Dr,Aurora, Colora, U.S.A

    Updated: 2019-01-18 20:58:02 (GMT+9)

    Call For Papers - CFP

    OVERVIEW

    The benefits of applying the quality by design in pharmaceutical development have been well advertised. Most important are the direct benefits to our primary customer; the patient.

    Per Janet Woodcock M.D. Director, Center for Drug Evaluation and Research (CDER), Food and Drug Administration

    “All products are designed and developed to be of high quality"

    QbD provides a structured framework for developing, documenting and presenting development rationale, experience and knowledge of the formulation and the process, and to ensure manufacture of products consistently fit for patient use.” Application of these principles can also benefit the pharmaceutical companies by improving manufacturing efficiency and promoting innovation.

    WHY SHOULD YOU ATTEND

    However, implementing these principles into the pharmaceutical development culture can be challenging.

    QbDin pharmaceuticals involves a complex set of interactions, technologies and systems that are not easy to grasp. This training will explain the main principles behind a QbD approach and provide guidelines in how to implement the concepts into a pharmaceutical development organization.

    Topics covered will include the target product quality profile, risk assessment, methods to establish a design space, and design of a control strategy. This review will help bridge the gap between understanding the principles and practical application.

    AREAS COVERED

    • Quality Target Product Profile (QTPP)

    • Risk Assessment

    • Using Models

    • Design of Experiments

    • Developing a Design Space

    • Process Analytical Technology (PAT)

    • FMEA and Control Plan

    • Target Operational Profile

    • Control Strategy

    LEARNING OBJECTIVES

    This training will explain the main principles behind a QbD approach and provide guidelines in how to implement the concepts into a pharmaceutical development organization.

    WHO WILL BENEFIT

    This course is designed for people tasked with developing, filing, and manufacturing pharmaceutical products especially small molecule oral dosage forms.This includes individuals that have responsibilities for formulation development, scale-up, filing, and commercial manufacture of dosage forms as well as maintaining the high quality of those products.

    Following personnel will benefit from the course:

    • Senior quality managers

    • Quality professionals

    • Regulatory professionals

    • Compliance professionals

    • Production supervisors

    • Manufacturing engineers

    • Production engineers

    • Process owners

    • Quality engineers

    • Quality auditors

    • Development professionals

    • Senior development managers

    For more detail please click on this below link:

    https://bit.ly/2sALkw2

    Email: supportattrainingdoyens.com

    Toll Free: +1-888-300-8494

    Tel: +1-720-996-1616

    Fax: +1-888-909-1882


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.